Similarly, a meta-analysis of transcriptomic datasets found the IL-4 and IL-13 Reactome pathway to be among the top 20 significant pathways in HS lesional versus non-lesional skin [14]. The gene discussed is IL13; the disease is histiocytic sarcoma.